Literature DB >> 21278042

Management of treatment-related symptoms in patients with breast cancer.

Sabrina Brem1, Nagi B Kumar.   

Abstract

Although the benefits of current treatment strategies are well established, many cancer survivors are at risk for developing physiologic and psychological late effects of cancer treatment that might lead to premature mortality and morbidity and compromise their quality of life. Psychological symptoms include anxiety, depression, fatigue, difficulty sleeping, and loss of self-esteem. Physiologic symptoms include pain, numbness, cognitive impairment, weight gain, loss of sexual interest, spontaneous menopause, and peripheral neuropathy. Both length and quality of survival are important end points. The goal of this review is to summarize the psychological and physiologic symptoms related to breast cancer treatment; the prevalence, contributing therapies, and inter-relatedness of these symptoms; current interventions to prevent, ameliorate, or treat these symptoms; and effectiveness and safety of these interventions. The results of this review will identify the gaps in knowledge and assist in the design of assessments and approaches to improve mortality and quality of life and provide the foundation for the development of evidence-based guidelines to standardize palliative care in cancer survivors.

Entities:  

Mesh:

Year:  2011        PMID: 21278042     DOI: 10.1188/11.CJON.63-71

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  8 in total

1.  Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer.

Authors:  Sonia Ancoli-Israel; Michelle Rissling; Ariel Neikrug; Vera Trofimenko; Loki Natarajan; Barbara A Parker; Susan Lawton; Paul Desan; Lianqi Liu
Journal:  Support Care Cancer       Date:  2011-06-11       Impact factor: 3.603

2.  Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy.

Authors:  Hyojung Park; Hyeon Gyeong Yoon
Journal:  Support Care Cancer       Date:  2013-04-25       Impact factor: 3.603

Review 3.  Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.

Authors:  Adedayo A Onitilo; Jessica M Engel; Rachel V Stankowski
Journal:  Ther Adv Drug Saf       Date:  2014-08

4.  Decreased Cortisol and Pain in Breast Cancer: Biofield Therapy Potential.

Authors:  Alice Running
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-11       Impact factor: 2.629

5.  Qigong program on insomnia and stress in cancer patients: A case series report.

Authors:  Seungmo Kim; Sangnam Lee; Osung Kwon; Seonghoon Park; Jungchul Seo; Kyungsoon Kim
Journal:  SAGE Open Med Case Rep       Date:  2015-01-14

6.  Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.

Authors:  Quentin Jacquinot; Nathalie Meneveau; Antoine Falcoz; Malika Bouhaddi; Pauline Roux; Bruno Degano; Marion Chatot; Elsa Curtit; Laura Mansi; Marie-Justine Paillard; Fernando Bazan; Loïc Chaigneau; Erion Dobi; Guillaume Meynard; Dewi Vernerey; Xavier Pivot; Fabienne Mougin
Journal:  Front Cardiovasc Med       Date:  2022-09-23

7.  At cancer diagnosis: a 'window of opportunity' for behavioural change towards physical activity. A randomised feasibility study in patients with colon and breast cancer.

Authors:  Tom Møller; Christian Lillelund; Christina Andersen; Bent Ejlertsen; Lone Nørgaard; Karl Bang Christensen; Eva Vadstrup; Finn Diderichsen; Carsten Hendriksen; Kira Bloomquist; Lis Adamsen
Journal:  BMJ Open       Date:  2013-11-04       Impact factor: 2.692

Review 8.  Considerations for payers in managing hormone receptor-positive advanced breast cancer.

Authors:  Mona Chitre; Kristen M Reimers
Journal:  Clinicoecon Outcomes Res       Date:  2014-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.